Friedrich Scheiflinger

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 292 citations · Full text

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Barbara Plaimauer, Klaus F. Zimmermann, Dirk Völkel et al. · Blood · 2002 · 229 citations

ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice

Frederik Denorme, Friederike Langhauser, Linda Desender et al. · Blood · 2016 · 179 citations · Full text

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

Anita Kruzik, Damir Fetahagic, Bettina Hartlieb et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 173 citations · Full text

Clinical Immunology, Immunohematology, Immunodeficiencies +27

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Barbara A. Konkle, Christopher Walsh, Miguel A. Escobar et al. · Blood · 2020 · 173 citations · Full text